Dr. Richard D Shusterman, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 |
Dr. Peter C Serpico, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 |
Dr. Bruce B Dershaw, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 |
Dr. Rudolf Khusid, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 |
Dr. Howard J Lee, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 |
Dr. John P Mahan, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 |
Benjamin Robert Solomon, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Floral Vale Blvd, Suite 125, Yardley, PA 19067 Phone: 215-785-9500 Fax: 215-785-9470 |
News Archive
The leader of The American Legion expressed disappointment today at the failure of Congress to okay an appropriations bill to fund the Department of Veterans Affairs during this new fiscal year, though a Continuing Resolution (CR) to provide additional funding for VA medical accounts was approved.
The first-in-human study of the NeuroBlate Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma, a malignant type of brain tumor.
The global COVID-19 pandemic affects all Australians and their loved ones at home and abroad. It is having a profound and enduring impact on our society, our resilience and our health.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
On the surface, it would seem as though the skin condition melasma (commonly referred to as the "mask of pregnancy") and tattoos would have little in common. However, they both affect a person's skin, can be quite difficult to treat or remove and, now, dermatologists are discovering new laser therapies which enhance treatment for both conditions.
› Verified 8 days ago